CCI Approves Platinum Poppy's Acquisition of Berhyanda and Berhyanda MidCo Shares

The Competition Commission of India has approved the acquisition of ordinary shares of Berhyanda Limited and Berhyanda MidCo Limited by Platinum Poppy C 2024 RSC Limited. Platinum Poppy will secure an indirect non-voting economic interest in Suven Pharmac

Abu Dhabi Investment AuthorityAdiaBerhyandaBerhyanda MidcoCompetition Commission Of IndiaCciPlatinum PoppyReal EstatePrivate EquityReal Estate NewsJul 18, 2024

CCI Approves Platinum Poppy's Acquisition of Berhyanda and Berhyanda MidCo Shares
Real Estate News:The Competition Commission of India (CCI) has given the green light to Platinum Poppy C 2024 RSC Limited to acquire ordinary shares of Berhyanda Limited (Berhyanda) and Berhyanda MidCo Limited (Berhyanda MidCo). The proposed combination involves the acquisition of ordinary shares and extension of shareholder debt to Berhyanda and Berhyanda MidCo by Platinum Poppy. This will result in Platinum Poppy securing an indirect non-voting economic interest in Suven Pharmaceuticals Limited (Suven), as Berhyanda currently holds 50.1% of the shareholding in Suven.

Platinum Poppy is a restricted scope company incorporated in the Abu Dhabi Global Market, established solely for the purpose of investing into Berhyanda and Berhyanda MidCo. Abu Dhabi Investment Authority (ADIA) is the ultimate beneficiary of Platinum Poppy. ADIA is a public institution established by the Government of the Emirate of Abu Dhabi as an independent investment institution. ADIA manages a global investment portfolio across more than two dozen asset classes and sub-categories, including developed equities, emerging market equities, small cap equities, government bonds, credit, fixed income, real estate, infrastructure, private equity, cash, and alternatives. In India, ADIA has made sector-agnostic investments and has previously invested in various sectors such as real estate, financial services, insurance, pharmaceuticals, and agrochemicals.

Berhyanda and Berhyanda MidCo are wholly owned by funds managed by Advent International, L.P. Both entities are investment holding companies. Suven Pharmaceuticals Limited is a public listed company incorporated in India and is listed on BSE Limited and National Stock Exchange Limited. Suven was incorporated in 2018 and is engaged in the manufacture and sale of active pharmaceutical ingredients and intermediates in India, and provision of contract development and manufacturing for intermediates in India.

A detailed order of the CCI will be released soon.

Frequently Asked Questions

What is the nature of Platinum Poppy's acquisition of Berhyanda and Berhyanda MidCo shares?

The acquisition involves the acquisition of ordinary shares and extension of shareholder debt to Berhyanda and Berhyanda MidCo by Platinum Poppy.

What is Abu Dhabi Investment Authority (ADIA)?

ADIA is a public institution established by the Government of the Emirate of Abu Dhabi as an independent investment institution.

What is the investment portfolio of ADIA?

ADIA manages a global investment portfolio across more than two dozen asset classes and sub-categories, including developed equities, emerging market equities, small cap equities, government bonds, credit, fixed income, real estate, infrastructure, private equity, cash, and alternatives.

What are Berhyanda and Berhyanda MidCo?

Both entities are investment holding companies, wholly owned by funds managed by Advent International, L.P.

What is Suven Pharmaceuticals Limited engaged in?

Suven is engaged in the manufacture and sale of active pharmaceutical ingredients and intermediates in India, and provision of contract development and manufacturing for intermediates in India.

Related News Articles

Pune's Luxury Real Estate Market Soars with Record-Breaking Penthouse Sale
Real Estate Pune

Pune's Luxury Real Estate Market Soars with Record-Breaking Penthouse Sale

Lodha One Bund Garden's Emperor Palace penthouse sells for INR 37cr, setting a new benchmark for luxury living in Pune.

July 8, 2024
Read Article
Anant Raj Reports 75% Increase in Net Profit for Q2 FY25
Real Estate Mumbai

Anant Raj Reports 75% Increase in Net Profit for Q2 FY25

Anant Raj has announced a significant 75% increase in its net profit for the second quarter of the fiscal year 2025. The company also reported a 53.67% rise in its net consolidated total income. This robust growth is a testament to the company's strategic

October 28, 2024
Read Article
Anarock Predicts 40% Revenue Growth in FY25 Driven by Strong Housing Demand
real estate news

Anarock Predicts 40% Revenue Growth in FY25 Driven by Strong Housing Demand

Anarock, a leading real estate consultancy firm, expects a significant 40% revenue growth in the fiscal year 2025, primarily driven by robust housing demand. According to Chairman Puri, the company has been successful in identifying and addressing key cha

November 3, 2024
Read Article
Bhopal's Urban Development: Growth Amidst a Legacy of Contamination
Real Estate Mumbai

Bhopal's Urban Development: Growth Amidst a Legacy of Contamination

Despite the devastating gas leak in 1984, Bhopal has seen gradual urban and real estate development, though fears of contamination still persist.

December 1, 2024
Read Article
Tragic Accident in Mumbai: Worli Car Crash Claims Life of Gate Employee
Real Estate Maharashtra

Tragic Accident in Mumbai: Worli Car Crash Claims Life of Gate Employee

A tragic incident unfolded in Worli, Mumbai, where a resident lost control of his car, leading to a fatal collision with a gate employee. The accident occurred around 7:45 PM, causing the car to crash into a compound wall after hitting the victim.

December 13, 2024
Read Article
Pune: DPU Honours Dr Tony Nader and Dr Sadanand Sardeshmukh at Convocation Ceremony
Real Estate Pune

Pune: DPU Honours Dr Tony Nader and Dr Sadanand Sardeshmukh at Convocation Ceremony

Dr DY Patil Vidyapeeth (DPU) honoured Dr Tony Nader and Dr Sadanand Sardeshmukh with Doctor of Science (Honoris Causa) degrees during the convocation ceremony, coinciding with the 8th International Ayurveda Congress 2025.

February 2, 2025
Read Article